FDA Withdraws Approval of New Drug Application for Primidone Suspension

Summary

The Food and Drug Administration (FDA) has withdrawn its approval of a new drug application for MYSOLINE (primidone) suspension, 250 milligrams/5 milliliters, submitted by FHTA LLC, citing reasons not specified by the agency.